VYTRUS BIOTECH, S.A. revenue for the last year amounted to 3.74 M EUR, the most of which — 3.55 M EUR — came from its highest performing source at the moment, Plant Stem Cells, the year earlier bringing 1.66 M EUR. The greatest contribution to the revenue figure was made by Spain — last year it brought VYTRUS BIOTECH, S.A. 1.47 M EUR, and the year before that — 787.25 k EUR.